HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gunasingh Masilamoni Selected Research

2- carbomethoxy- 3- (4- chlorophenyl)- 8- (2- fluoroethyl)nortropane

12/2010(18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gunasingh Masilamoni Research Topics

Disease

3Parkinsonian Disorders (Parkinsonism)
10/2020 - 12/2010
1Inflammation (Inflammations)
10/2020

Drug/Important Bio-Agent (IBA)

31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2020 - 12/2010
1XENP 1595IBA
10/2020
1Tumor Necrosis Factor InhibitorsIBA
10/2020
12- carbomethoxy- 3- (4- chlorophenyl)- 8- (2- fluoroethyl)nortropaneIBA
12/2010
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2010
1Dopamine (Intropin)FDA LinkGeneric
12/2010
1LigandsIBA
12/2010

Therapy/Procedure

1Denervation
12/2010
1Injections
12/2010